company background image
EVH logo

Evolent Health Informe acción NYSE:EVH

Último precio

US$23.27

Capitalización de mercado

US$2.6b

7D

-1.2%

1Y

-24.6%

Actualizada

22 May, 2024

Datos

Finanzas de la empresa +

Evolent Health, Inc.

Informe acción NYSE:EVH

Capitalización de mercado: US$2.6b

Resumen de acción EVH

Evolent Health, Inc. a través de su filial Evolent Health LLC, ofrece servicios de gestión de cuidados especializados en los mercados de oncología, cardiología y musculoesquelético en Estados Unidos.

EVH fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Competidores de Evolent Health, Inc.

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Evolent Health
Historical stock prices
Current Share PriceUS$23.27
52 Week HighUS$35.00
52 Week LowUS$22.58
Beta1.57
1 Month Change-22.07%
3 Month Change-21.83%
1 Year Change-24.64%
3 Year Change20.32%
5 Year Change132.47%
Change since IPO23.38%

Noticias y actualizaciones recientes

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Recent updates

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Is Evolent Health (NYSE:EVH) A Risky Investment?

Aug 05
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health initiated at outperform at RBC on organic revenue growth opportunity

Jul 29

Rentabilidad de los accionistas

EVHUS Healthcare ServicesMercado US
7D-1.2%-0.4%-0.2%
1Y-24.6%-1.8%28.2%

Rentabilidad vs. Industria: EVH obtuvo unos resultados inferiores a los del sector US Healthcare Services , que el año pasado arrojó un rendimiento del -10.4%.

Rentabilidad vs. Mercado: EVH obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.

Volatilidad de los precios

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement5.9%
Healthcare Services Industry Average Movement10.6%
Market Average Movement5.9%
10% most volatile stocks in US Market16.0%
10% least volatile stocks in US Market2.8%

Precio estable de las acciones: El precio de las acciones de EVH ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de EVH (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
20114,700Seth Blackleywww.evolent.com

Evolent Health, Inc. a través de su filial Evolent Health LLC, ofrece servicios de gestión de atención especializada en los mercados de oncología, cardiología y musculoesquelético en Estados Unidos. La empresa proporciona plataformas para la administración de planes de salud e infraestructuras empresariales basadas en el valor. Ofrece servicios administrativos, como servicios de planes de salud, gestión de beneficios farmacéuticos, gestión de riesgos, análisis e informes, y liderazgo y gestión; e Identifi, un sistema tecnológico propio que agrega y analiza datos, gestiona flujos de trabajo asistenciales e involucra a los pacientes.

Resumen de fundamentos de Evolent Health, Inc.

¿Cómo se comparan los beneficios e ingresos de Evolent Health con su capitalización de mercado?
Estadísticas fundamentales de EVH
Capitalización bursátilUS$2.64b
Beneficios(TTM)-US$141.23m
Ingresos (TTM)US$2.18b

1.2x

Ratio precio-ventas (PS)

-18.9x

Ratio precio-beneficio (PE)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de EVH
IngresosUS$2.18b
Coste de los ingresosUS$1.73b
Beneficio brutoUS$447.36m
Otros gastosUS$588.59m
Beneficios-US$141.23m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)-1.23
Margen bruto20.56%
Margen de beneficio neto-6.49%
Ratio deuda/patrimonio48.6%

¿Cómo se ha desempeñado EVH a largo plazo?

Ver rendimiento histórico y comparativa